Neovacs Announces the Results of its Phase IIb Study for Ifnalpha Kinoid in the Treatment of Lupus Which Allows to Proceed With the Clinical Development into Phase III
July 3, 2018
Neovacs announced the results of its Phase IIb clinical trial of the investigational agent IFNalpha Kinoid in...